{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:34:41Z","timestamp":1790426081683,"version":"4.1.0"},"reference-count":198,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DE023342"],"award-info":[{"award-number":["DE023342"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["A2013171S"],"award-info":[{"award-number":["A2013171S"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007165","name":"University of Missouri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.neuropharm.2015.10.031","type":"journal-article","created":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T23:17:47Z","timestamp":1446506267000},"page":"169-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["Purinergic receptors as potential therapeutic targets in Alzheimer's disease"],"prefix":"10.1016","volume":"104","author":[{"given":"Lucas T.","family":"Woods","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Ajit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Camden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Erb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Weisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.10.031_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/pr.58.3.3","article-title":"International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy","volume":"58","author":"Abbracchio","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11302-006-9033-z","article-title":"P1 receptors and cytokine secretion","volume":"3","author":"Abbracchio","year":"2007","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jnci\/92.4.321","article-title":"Randomized clinical trial of adenosine 5\u2032-triphosphate in patients with advanced non-small-cell lung cancer","volume":"92","author":"Agteresch","year":"2000","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1212\/WNL.54.3.588","article-title":"A\u00a0randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's disease cooperative study","volume":"54","author":"Aisen","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib5","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1001\/jama.289.21.2819","article-title":"Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial","volume":"289","author":"Aisen","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib6","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s12035-013-8577-5","article-title":"Loss of P2Y2 nucleotide receptors enhances early pathology in the TgCRND8 mouse model of Alzheimer's disease","volume":"49","author":"Ajit","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-3639.2007.00112.x","article-title":"Up-regulation of adenosine receptors in the frontal cortex in Alzheimer's disease","volume":"18","author":"Albasanz","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib8","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1750-3639.2003.tb00475.x","article-title":"A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation","volume":"13","author":"Angulo","year":"2003","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1742-4658.2008.06796.x","article-title":"Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events","volume":"276","author":"Apolloni","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuroscience.2006.07.021","article-title":"Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain \u03b2-amyloid production","volume":"142","author":"Arendash","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib11","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1517\/13543784.2011.578068","article-title":"A\u00a0potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases","volume":"20","author":"Arulkumaran","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson's disease in men and women","volume":"50","author":"Ascherio","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib13","doi-asserted-by":"crossref","first-page":"39050","DOI":"10.1074\/jbc.M504819200","article-title":"The P2Y2 nucleotide receptor interacts with \u03b1v integrins to activate Go and induce cell migration","volume":"280","author":"Bagchi","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib14","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jpainsymman.2010.01.023","article-title":"Randomized clinical trial on the effects of adenosine 5\u2032-triphosphate infusions on quality of life, functional status, and fatigue in preterminal cancer patients","volume":"40","author":"Beijer","year":"2010","journal-title":"J.\u00a0Pain Symptom Manag."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib15","first-page":"275","article-title":"P2Y receptor antagonists in thrombosis","volume":"6","author":"Boeynaems","year":"2005","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib16","first-page":"1443","article-title":"P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation","volume":"3","author":"Bours","year":"2011","journal-title":"Front. Biosci. (Schol. Ed.)"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0404.1996.tb05866.x","article-title":"Evolution of the neuropathology of Alzheimer's disease","volume":"165","author":"Braak","year":"1996","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/156720506777632817","article-title":"Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent","volume":"3","author":"Brinton","year":"2006","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrn3710","article-title":"Microglial phagocytosis of live neurons","volume":"15","author":"Brown","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2015.10.031_bib20","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1038\/sj.bjp.0706429","article-title":"Purinergic signalling","volume":"147","author":"Burnstock","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrd2605","article-title":"Purinergic signalling and disorders of the central nervous system","volume":"7","author":"Burnstock","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1476-5381.2010.00937.x","article-title":"Control of vascular tone by purines and pyrimidines","volume":"161","author":"Burnstock","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neuropharm.2015.05.031","article-title":"An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration","volume":"104","author":"Burnstock","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1476-5381.1972.tb07283.x","article-title":"Atropine resistant excitation of the urinary bladder: the possibility of transmission via nerves releasing a purine nucleotide","volume":"44","author":"Burnstock","year":"1972","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pneurobio.2011.08.006","article-title":"Purinergic signalling: from normal behaviour to pathological brain function","volume":"95","author":"Burnstock","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib26","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1038\/cddis.2009.11","article-title":"Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death","volume":"1","author":"Burnstock","year":"2010","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib27","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1750-3639.2004.tb00087.x","article-title":"Amyloid \u03b2-peptide1-42 contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain","volume":"14","author":"Butterfield","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib28","doi-asserted-by":"crossref","first-page":"18696","DOI":"10.1074\/jbc.M500219200","article-title":"P2Y2 nucleotide receptors enhance \u03b1-secretase-dependent amyloid precursor protein processing","volume":"280","author":"Camden","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib29","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/302553","article-title":"Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum","volume":"65","author":"Campion","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib30","doi-asserted-by":"crossref","first-page":"14741","DOI":"10.1523\/JNEUROSCI.3728-09.2009","article-title":"Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by \u03b2-amyloid peptides via p38 mitogen-activated protein kinase pathway","volume":"29","author":"Canas","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3233\/JAD-2009-1071","article-title":"Caffeine suppresses amyloid-\u03b2 levels in plasma and brain of Alzheimer's disease transgenic mice","volume":"17","author":"Cao","year":"2009","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib32","doi-asserted-by":"crossref","first-page":"13272","DOI":"10.1523\/JNEUROSCI.3337-11.2011","article-title":"Adenosine receptor signaling modulates permeability of the blood-brain barrier","volume":"31","author":"Carman","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib33","doi-asserted-by":"crossref","first-page":"e1102","DOI":"10.1038\/cddis.2014.70","article-title":"Extracellular ATP drives systemic inflammation, tissue damage and mortality","volume":"5","author":"Cauwels","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib34","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1523\/JNEUROSCI.22-08-03061.2002","article-title":"ADP and AMP induce interleukin-1\u03b2 release from microglial cells through activation of ATP-primed P2X7 receptor channels","volume":"22","author":"Chakfe","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib35","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1002\/jnr.21071","article-title":"Activation of adenosine A3 receptors reduces ischemic brain injury in rodents","volume":"84","author":"Chen","year":"2006","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib36","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.4049\/jimmunol.176.5.3115","article-title":"Exacerbation of experimental autoimmune encephalomyelitis in P2X7R-\/- mice: evidence for loss of apoptotic activity in lymphocytes","volume":"176","author":"Chen","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuroscience.2014.08.036","article-title":"Brilliant Blue G improves cognition in an animal model of Alzheimer's disease and inhibits amyloid-\u03b2-induced loss of filopodia and dendrite spines in hippocampal neurons","volume":"279","author":"Chen","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0031-6997(24)01512-6","article-title":"P2X receptors and nociception","volume":"53","author":"Chizh","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/B978-0-444-63380-4.00002-0","article-title":"P2X7 antagonists as potential therapeutic agents for the treatment of CNS disorders","volume":"53","author":"Chrovian","year":"2014","journal-title":"Prog. Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1742-2094-9-69","article-title":"Inhibition of P2X7 receptor ameliorates transient global cerebral ischemia\/reperfusion injury via modulating inflammatory responses in the rat hippocampus","volume":"9","author":"Chu","year":"2012","journal-title":"J.\u00a0Neuroinflamm."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib41","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2174\/187152710791011991","article-title":"Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease","volume":"9","author":"Cole","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib42","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0028-3908(97)00140-8","article-title":"Tissue distribution of the P2X7 receptor","volume":"36","author":"Collo","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib43","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1523\/JNEUROSCI.21-04-01179.2001","article-title":"\u03b2-Amyloid stimulation of microglia and monocytes results in TNF\u03b1-dependent expression of inducible nitric oxide synthase and neuronal apoptosis","volume":"21","author":"Combs","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib44","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1096\/fj.15-272450","article-title":"Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing","volume":"29","author":"Csoka","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1056\/NEJMra040223","article-title":"Alzheimer's disease","volume":"351","author":"Cummings","year":"2004","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib46","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1365-2559.2001.01082.x","article-title":"Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease","volume":"38","author":"D'Andrea","year":"2001","journal-title":"Histopathology"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.expneurol.2006.08.008","article-title":"Caffeine and adenosine A2A receptor antagonists prevent \u03b2-amyloid25-35-induced cognitive deficits in mice","volume":"203","author":"Dall'Igna","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib48","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.bjp.0705185","article-title":"Neuroprotection by caffeine and adenosine A2A receptor blockade of \u03b2-amyloid neurotoxicity","volume":"138","author":"Dall'Igna","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib49","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nn1472","article-title":"ATP mediates rapid microglial response to local brain injury in\u00a0vivo","volume":"8","author":"Davalos","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib50","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1038\/ncomms6422","article-title":"Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in\u00a0vivo in an Alzheimer's disease mouse model","volume":"5","author":"Delekate","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nrn2822","article-title":"New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?","volume":"11","author":"Deng","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib52","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/biof.5520080318","article-title":"ATP as a death factor","volume":"8","author":"Di Virgilio","year":"1998","journal-title":"Biofactors"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib53","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.tips.2007.07.002","article-title":"Liaisons dangereuses: P2X7 and the inflammasome","volume":"28","author":"Di Virgilio","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib54","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1097\/00001756-200107030-00014","article-title":"Adenosine A2A agonist CGS 21680 decreases the affinity of dopamine D2 receptors for dopamine in human striatum","volume":"12","author":"Diaz-Cabiale","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib55","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.neurobiolaging.2011.09.040","article-title":"In\u00a0vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3\u03b2 and secretases","volume":"33","author":"Diaz-Hernandez","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib56","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1096\/fj.08-122275","article-title":"Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration","volume":"23","author":"Diaz-Hernandez","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib57","doi-asserted-by":"crossref","first-page":"C83","DOI":"10.1152\/ajpcell.00380.2013","article-title":"P2Y2 nucleotide receptor activation enhances the aggregation and self-organization of dispersed salivary epithelial cells","volume":"307","author":"El-Sayed","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib58","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1074\/jbc.270.9.4185","article-title":"Site-directed mutagenesis of P2U purinoceptors. Positively charged amino acids in transmembrane helices 6 and 7 affect agonist potency and specificity","volume":"270","author":"Erb","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib59","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1083\/jcb.153.3.491","article-title":"An RGD sequence in the P2Y2 receptor interacts with \u03b1v\u03b23 integrins and is required for Go-mediated signal transduction","volume":"153","author":"Erb","year":"2001","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib60","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.1016\/S0021-9258(19)39131-8","article-title":"Covalent incorporation of 3\u2032-O-(4-benzoyl)benzoyl-ATP into a P2 purinoceptor in transformed mouse fibroblasts","volume":"265","author":"Erb","year":"1990","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib61","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/3305","article-title":"Neurogenesis in the adult human hippocampus","volume":"4","author":"Eriksson","year":"1998","journal-title":"Nat. Med."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2015.10.031_bib62","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.3233\/JAD-2010-1404","article-title":"Caffeine as a protective factor in dementia and Alzheimer's disease","volume":"20","author":"Eskelinen","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib63","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.freeradbiomed.2010.04.031","article-title":"The purinergic P2Y13 receptor activates the Nrf2\/HO-1 axis and protects against oxidative stress-induced neuronal death","volume":"49","author":"Espada","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib64","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrn1928","article-title":"Purinergic signalling in neuron-glia interactions","volume":"7","author":"Fields","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib65","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11010-005-8050-5","article-title":"Agonist-induced phosphorylation and desensitization of the P2Y2 nucleotide receptor","volume":"280","author":"Flores","year":"2005","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11302-011-9271-6","article-title":"In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization","volume":"8","author":"Ford","year":"2012","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib67","first-page":"307","article-title":"Microglial response to amyloid plaques in APPsw transgenic mice","volume":"152","author":"Frautschy","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib68","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","article-title":"International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors","volume":"53","author":"Fredholm","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib69","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-6997(24)01396-6","article-title":"Actions of caffeine in the brain with special reference to factors that contribute to its widespread use","volume":"51","author":"Fredholm","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib70","doi-asserted-by":"crossref","first-page":"260925","DOI":"10.1155\/2013\/260925","article-title":"Role of neuroinflammation in adult neurogenesis and Alzheimer disease: therapeutic approaches","volume":"2013","author":"Fuster-Matanzo","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib71","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jnc.12286","article-title":"P2X7 receptor-induced death of motor neurons by a peroxynitrite\/FAS-dependent pathway","volume":"126","author":"Gandelman","year":"2013","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib72","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11302-011-9233-z","article-title":"Nucleotide receptors as targets in the pharmacological enhancement of dermal wound healing","volume":"7","author":"Gendaszewska-Darmach","year":"2011","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib73","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/mp.2011.52","article-title":"APOE and Alzheimer disease: a major gene with semi-dominant inheritance","volume":"16","author":"Genin","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib74","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of A\u03b2 immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib75","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1001\/jama.2009.1866","article-title":"Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial","volume":"302","author":"Green","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib76","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","article-title":"Brain interleukin 1 and S-100 immunoreactivity are elevated in down syndrome and Alzheimer disease","volume":"86","author":"Griffin","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib77","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1523\/JNEUROSCI.19-02-00520.1999","article-title":"ATP released from astrocytes mediates glial calcium waves","volume":"19","author":"Guthrie","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib78","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib79","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1474-4422(11)70012-6","article-title":"Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial","volume":"10","author":"Hauser","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib80","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1474-4422(14)70148-6","article-title":"Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial","volume":"13","author":"Hauser","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib81","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/nn1805","article-title":"The P2Y12 receptor regulates microglial activation by extracellular nucleotides","volume":"9","author":"Haynes","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib82","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010-2050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib83","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: the role of inflammation in Alzheimer disease","volume":"16","author":"Heppner","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib84","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1471-4159.2000.0750965.x","article-title":"Extracellular ATP triggers tumor necrosis factor-\u03b1 release from rat microglia","volume":"75","author":"Hide","year":"2000","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib85","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib86","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.2353\/ajpath.2010.100346","article-title":"A\u03b2 accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model","volume":"177","author":"Hurtado","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib87","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nature13085","article-title":"Nucleotide signalling during inflammation","volume":"509","author":"Idzko","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib88","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/1073858411418524","article-title":"P2X receptors and their roles in astroglia in the central and peripheral nervous system","volume":"18","author":"Illes","year":"2012","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib89","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0306-4522(90)90246-Z","article-title":"Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors\u2013an autoradiographic study","volume":"39","author":"Jansen","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib90","doi-asserted-by":"crossref","first-page":"17179","DOI":"10.1073\/pnas.252537299","article-title":"A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2\/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat","volume":"99","author":"Jarvis","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib91","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1124\/mol.58.1.82","article-title":"Brilliant blue G selectively blocks ATP-gated rat P2X7 receptors","volume":"58","author":"Jiang","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib92","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-3940(90)90641-L","article-title":"Hippocampal adenosine A1 receptors are decreased in Alzheimer's disease","volume":"118","author":"Kalaria","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib93","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1096-9861(19990428)407:1<11::AID-CNE2>3.0.CO;2-R","article-title":"Distribution of the P2X2 receptor subunit of the ATP-gated ion channels in the rat central nervous system","volume":"407","author":"Kanjhan","year":"1999","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib94","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nature04886","article-title":"P2X receptors as cell-surface ATP sensors in health and disease","volume":"442","author":"Khakh","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib95","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1471-4159.2012.07700.x","article-title":"Nucleotides released from A\u03b21-42-treated microglial cells increase cell migration and A\u03b21-42 uptake through P2Y2 receptor activation","volume":"121","author":"Kim","year":"2012","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib96","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/emm.2007.89","article-title":"ATP released from \u03b2-amyloid-stimulated microglia induces reactive oxygen species production in an autocrine fashion","volume":"39","author":"Kim","year":"2007","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib97","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/glia.22358","article-title":"Purinergic receptors in microglia: functional modal shifts of microglia mediated by P2 and P1 receptors","volume":"61","author":"Koizumi","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib98","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/nature05704","article-title":"UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis","volume":"446","author":"Koizumi","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib99","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.2174\/138161207781368747","article-title":"Purine ionotropic (P2X) receptors","author":"Koles","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib100","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1471-4159.2009.06048.x","article-title":"Interleukin-1\u03b2 enhances nucleotide-induced and \u03b1-secretase-dependent amyloid precursor protein processing in rat primary cortical neurons via up-regulation of the P2Y2 receptor","volume":"109","author":"Kong","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib101","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11302-005-7145-5","article-title":"P2X7 nucleotide receptors mediate caspase-8\/9\/3-dependent apoptosis in rat primary cortical neurons","volume":"1","author":"Kong","year":"2005","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib102","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.1073\/pnas.88.16.7247","article-title":"An in\u00a0vivo model for the neurodegenerative effects of \u03b2-amyloid and protection by substance P","volume":"88","author":"Kowall","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib103","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/jcbfm.2011.49","article-title":"Astrocytic P2Y1 receptor is involved in the regulation of cytokine\/chemokine transcription and cerebral damage in a rat model of cerebral ischemia","volume":"31","author":"Kuboyama","year":"2011","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib104","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1126\/science.1169096","article-title":"Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice","volume":"323","author":"Kuchibhotla","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib105","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1523\/JNEUROSCI.16-06-02027.1996","article-title":"Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation","volume":"16","author":"Kuhn","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib106","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00702-008-0067-y","article-title":"Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer's disease neuropathology","volume":"115","author":"Lai","year":"2008","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib107","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3858\/emm.2011.43.1.001","article-title":"Microglial P2X7 receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe\/PS1dE9 mouse model of Alzheimer's disease","volume":"43","author":"Lee","year":"2011","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib108","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nm1096-1146","article-title":"The E280A presenilin 1 Alzheimer mutation produces increased A\u03b2 42 deposition and severe cerebellar pathology","volume":"2","author":"Lemere","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib109","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ana.21315","article-title":"Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces \u201coff\u201d time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005)","volume":"63","author":"LeWitt","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib110","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1128\/MCB.00544-13","article-title":"P2Y4 receptor-mediated pinocytosis contributes to amyloid \u03b2-induced self-uptake by microglia","volume":"33","author":"Li","year":"2013","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib111","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1242\/jcs.03441","article-title":"The P2Y2 nucleotide receptor requires interaction with \u03b1v integrins to access and activate G12","volume":"120","author":"Liao","year":"2007","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib112","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-9255-4-5","article-title":"The role of the purinergic P2X7 receptor in inflammation","volume":"4","author":"Lister","year":"2007","journal-title":"J.\u00a0Inflamm. (Lond.)"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib113","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/brain\/awu330","article-title":"Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states","volume":"138","author":"Little","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib114","doi-asserted-by":"crossref","first-page":"8212","DOI":"10.1074\/jbc.M312230200","article-title":"Src homology 3 binding sites in the P2Y2 nucleotide receptor interact with Src and regulate activities of Src, proline-rich tyrosine kinase 2, and growth factor receptors","volume":"279","author":"Liu","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib115","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1165\/rcmb.2010-0038OC","article-title":"P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysema","volume":"44","author":"Lucattelli","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"Pt 3","key":"10.1016\/j.neuropharm.2015.10.031_bib116","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1042\/bj2840733","article-title":"A\u00a0nucleotide receptor in vascular endothelial cells is specifically activated by the fully ionized forms of ATP and UTP","volume":"284","author":"Lustig","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib117","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1468-1331.2002.00421.x","article-title":"Does caffeine intake protect from Alzheimer's disease?","volume":"9","author":"Maia","year":"2002","journal-title":"Eur. J. Neurol. Soc."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib118","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/nlme.2000.3991","article-title":"Hippocampal injections of amyloid \u03b2-peptide 1-40 impair subsequent one-trial\/day reward learning","volume":"76","author":"Malin","year":"2001","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib119","doi-asserted-by":"crossref","first-page":"9525","DOI":"10.1523\/JNEUROSCI.0579-07.2007","article-title":"P2X7 receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis","volume":"27","author":"Matute","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib120","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/sj.bjp.0705574","article-title":"Effects of A-317491, a novel and selective P2X3\/P2X2\/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration","volume":"140","author":"McGaraughty","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib121","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/01.jnen.0000240470.97295.d3","article-title":"Upregulated expression of purinergic P2X7 receptor in Alzheimer disease and amyloid-\u03b2 peptide-treated microglia and in peptide-injected rat hippocampus","volume":"65","author":"McLarnon","year":"2006","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib122","doi-asserted-by":"crossref","first-page":"e17338","DOI":"10.1371\/journal.pone.0017338","article-title":"Adenosine A2A receptors measured with [C]TMSX PET in the striata of Parkinson's disease patients","volume":"6","author":"Mishina","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib123","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1242\/dev.02233","article-title":"Extracellular nucleotide signaling in adult neural stem cells: synergism with growth factor-mediated cellular proliferation","volume":"133","author":"Mishra","year":"2006","journal-title":"Development"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib124","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1523\/JNEUROSCI.5512-08.2009","article-title":"The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore","volume":"29","author":"Monif","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib125","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1097\/00001756-200011270-00041","article-title":"Immunohistochemical localization of the P2Y1 purinergic receptor in Alzheimer's disease","volume":"11","author":"Moore","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib126","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0079-6123(10)83010-9","article-title":"Pathophysiological roles for purines: adenosine, caffeine and urate","volume":"183","author":"Morelli","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib127","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1750-1326-6-85","article-title":"Adult hippocampal neurogenesis and its role in Alzheimer's disease","volume":"6","author":"Mu","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib128","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0006-8993(03)02361-8","article-title":"Astrocytes accumulate A\u03b2 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains","volume":"971","author":"Nagele","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib129","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/glia.22693","article-title":"Inhibition of UDP\/P2Y6 purinergic signaling prevents phagocytosis of viable neurons by activated microglia in\u00a0vitro and in\u00a0vivo","volume":"62","author":"Neher","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib130","doi-asserted-by":"crossref","first-page":"39904","DOI":"10.1074\/jbc.M111.267583","article-title":"Neuronal death induced by nanomolar amyloid \u03b2 is mediated by primary phagocytosis of neurons by microglia","volume":"286","author":"Neniskyte","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib131","doi-asserted-by":"crossref","first-page":"G795","DOI":"10.1152\/ajpgi.2001.280.5.G795","article-title":"P2Y11, a purinergic receptor acting via cAMP, mediates secretion by pancreatic duct epithelial cells","volume":"280","author":"Nguyen","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib132","first-page":"891087","article-title":"Sweepers in the CNS: microglial migration and phagocytosis in the Alzheimer disease pathogenesis","volume":"2012","author":"Noda","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib133","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and Alzheimer's disease","volume":"34","author":"O'Brien","year":"2011","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib134","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s11064-011-0475-5","article-title":"Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology","volume":"36","author":"Obulesu","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib135","doi-asserted-by":"crossref","first-page":"e975","DOI":"10.1038\/cddis.2013.503","article-title":"Oligomeric amyloid \u03b2 induces IL-1\u03b2 processing via production of ROS: implication in Alzheimer's disease","volume":"4","author":"Parajuli","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib136","doi-asserted-by":"crossref","first-page":"13309","DOI":"10.1074\/jbc.M209478200","article-title":"P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease","volume":"278","author":"Parvathenani","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib137","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-2-9","article-title":"Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease","volume":"2","author":"Patel","year":"2005","journal-title":"J.\u00a0Neuroinflamm."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib138","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2013.12.071","article-title":"The dual role of astrocyte activation and reactive gliosis","volume":"565","author":"Pekny","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib139","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.4049\/jimmunol.165.8.4615","article-title":"ATP acts as an agonist to promote stimulus-induced secretion of IL-1\u03b2 and IL-18 in human blood","volume":"165","author":"Perregaux","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib140","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12035-010-8115-7","article-title":"P2Y2 nucleotide receptor-mediated responses in brain cells","volume":"41","author":"Peterson","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib141","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/jnc.12252","article-title":"Up-regulation and activation of the P2Y2 nucleotide receptor mediate neurite extension in IL-1\u03b2-treated mouse primary cortical neurons","volume":"125","author":"Peterson","year":"2013","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib142","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.bbamem.2010.05.021","article-title":"Structural features of adenosine receptors: from crystal to function","volume":"1808","author":"Piirainen","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib143","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s40263-014-0161-7","article-title":"Adenosine A2A receptor antagonists in Parkinson's disease: progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued","volume":"28","author":"Pinna","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib144","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroscience.2005.03.050","article-title":"Uridine enhances neurite outgrowth in nerve growth factor-differentiated PC12 [corrected]","volume":"134","author":"Pooler","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib145","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2174\/187152712803581100","article-title":"Potential therapeutic relevance of adenosine A2B and A2A receptors in the central nervous system","volume":"11","author":"Popoli","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib146","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1523\/JNEUROSCI.22-05-01967.2002","article-title":"Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum","volume":"22","author":"Popoli","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib147","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/157015909789152119","article-title":"The role of adenosine in Alzheimer's disease","volume":"7","author":"Rahman","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib148","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.1074\/jbc.M109.078170","article-title":"P2Y2 nucleotide receptors mediate metalloprotease-dependent phosphorylation of epidermal growth factor receptor and ErbB3 in human salivary gland cells","volume":"285","author":"Ratchford","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2014.01.083","article-title":"Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review","volume":"101","author":"Rivera-Oliver","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib150","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1523\/JNEUROSCI.0628-05.2005","article-title":"Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2\/3, and P2X3 and inhibitory P2Y1, P2Y2, and\/or P2Y4 receptors in the rat hippocampus","volume":"25","author":"Rodrigues","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib151","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1523\/JNEUROSCI.0696-08.2008","article-title":"Facilitation of P2X7 receptor currents and membrane blebbing via constitutive and dynamic calmodulin binding","volume":"28","author":"Roger","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib152","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1471-4159.2003.01825.x","article-title":"The influence of brain inflammation upon neuronal adenosine A2B receptors","volume":"86","author":"Rosi","year":"2003","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib153","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1523\/JNEUROSCI.21-02-00641.2001","article-title":"Distinct localization of P2X receptors at excitatory postsynaptic specializations","volume":"21","author":"Rubio","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib154","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/WNR.0b013e3283179333","article-title":"Block of purinergic P2X7 receptor is neuroprotective in an animal model of Alzheimer's disease","volume":"19","author":"Ryu","year":"2008","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib155","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1212\/WNL.0b013e3181c67808","article-title":"A\u00a0phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease","volume":"73","author":"Salloway","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib156","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.4049\/jimmunol.0803612","article-title":"Activation of microglia by amyloid \u03b2 requires P2X7 receptor expression","volume":"182","author":"Sanz","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib157","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1212\/WNL.53.1.197","article-title":"A\u00a0double-blind, placebo-controlled trial of diclofenac\/misoprostol in Alzheimer's disease","volume":"53","author":"Scharf","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib158","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2174\/156720509790147179","article-title":"Microglial activation in Alzheimer's disease","volume":"6","author":"Schlachetzki","year":"2009","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib159","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ana.22365","article-title":"What the halted phase III \u03b3-secretase inhibitor trial may (or may not) be telling us","volume":"69","author":"Schor","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib160","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.tins.2006.09.004","article-title":"Targeting adenosine A2A receptors in Parkinson's disease","volume":"29","author":"Schwarzschild","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib161","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-2094-5-7","article-title":"The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective","volume":"5","author":"Shaftel","year":"2008","journal-title":"J.\u00a0Neuroinflamm."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib162","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/glia.22628","article-title":"P2X7-dependent, but differentially regulated release of IL-6, CCL2, and TNF-\u03b1 in cultured mouse microglia","volume":"62","author":"Shieh","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib163","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/35066584","article-title":"Neurogenesis in the adult is involved in the formation of trace memories","volume":"410","author":"Shors","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib164","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.neuropharm.2007.02.011","article-title":"Mechanisms of regulation for interleukin-1\u03b2 in neurodegenerative disease","volume":"52","author":"Simi","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib165","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neurobiolaging.2008.05.015","article-title":"Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain","volume":"31","author":"Simpson","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib166","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11302-006-9043-x","article-title":"Purinergic modulation of microglial cell activation","volume":"3","author":"Sperlagh","year":"2007","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib167","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1046\/j.1471-4159.2002.00920.x","article-title":"Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus","volume":"81","author":"Sperlagh","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib168","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pneurobio.2006.03.007","article-title":"P2X7 receptors in the nervous system","volume":"78","author":"Sperlagh","year":"2006","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib169","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1038\/onc.2010.292","article-title":"Extracellular adenosine triphosphate and adenosine in cancer","volume":"29","author":"Stagg","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib170","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1016\/S0021-9258(18)61477-2","article-title":"Extracellular ATP4\u2212 promotes cation fluxes in the J774 mouse macrophage cell line","volume":"262","author":"Steinberg","year":"1987","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib171","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/978-3-540-89615-9_17","article-title":"Adenosine receptors and neurological disease: neuroprotection and neurodegeneration","volume":"193","author":"Stone","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/JNEUROSCI.3792-03.2004","article-title":"Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia","volume":"24","author":"Suzuki","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib173","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1679\/aohc.59.485","article-title":"Cellular distribution of the P2X4 ATP receptor mRNA in the brain and non-neuronal organs of rats","volume":"59","author":"Tanaka","year":"1996","journal-title":"Arch. Histol. Cytol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib174","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1126\/scisignal.256pe6","article-title":"Extracellular ATP in the immune system: more than just a \u201cdanger signal\u201d","volume":"2","author":"Trautmann","year":"2009","journal-title":"Sci. Signal"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib175","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nature01786","article-title":"P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury","volume":"424","author":"Tsuda","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib176","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.brainresrev.2009.11.003","article-title":"Pain and purinergic signaling","volume":"63","author":"Tsuda","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib177","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0306-4522(93)90533-L","article-title":"Reduced density of adenosine A1 receptors and preserved coupling of adenosine A1 receptors to G proteins in Alzheimer hippocampus: a quantitative autoradiographic study","volume":"52","author":"Ulas","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib178","doi-asserted-by":"crossref","first-page":"11263","DOI":"10.1523\/JNEUROSCI.2308-08.2008","article-title":"Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain","volume":"28","author":"Ulmann","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib179","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.ejcn.1602495","article-title":"Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE study","volume":"61","author":"van Gelder","year":"2007","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib180","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/4151030a","article-title":"Functional neurogenesis in the adult hippocampus","volume":"415","author":"van Praag","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib181","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12017-009-8073-2","article-title":"Amyloid-\u03b2 induces a caspase-mediated cleavage of P2X4 to promote purinotoxicity","volume":"11","author":"Varma","year":"2009","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib182","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.4049\/jimmunol.166.10.6383","article-title":"ATP mediates calcium signaling between astrocytes and microglial cells: modulation by IFN-\u03b3","volume":"166","author":"Verderio","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib183","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.4049\/jimmunol.170.11.5728","article-title":"P2X7 receptor-dependent blebbing and the activation of Rho-effector kinases, caspases, and IL-1\u03b2 release","volume":"170","author":"Verhoef","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib184","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.tips.2004.07.008","article-title":"Molecular properties of ATP-gated P2X receptor ion channels","volume":"25","author":"Vial","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib185","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/annonc\/mdn412","article-title":"Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study","volume":"19","author":"Villalona-Calero","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib186","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.nbd.2014.05.030","article-title":"Increased striatal adenosine A2A receptor levels is an early event in Parkinson's disease-related pathology and it is potentially regulated by miR-34b","volume":"69","author":"Villar-Menendez","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib187","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1471-4159.2005.03408.x","article-title":"P2Y nucleotide receptor interaction with \u03b1 integrin mediates astrocyte migration","volume":"95","author":"Wang","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib188","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1113\/jphysiol.2004.066845","article-title":"P2X receptor subtype-specific modulation of excitatory and inhibitory synaptic inputs in the rat brainstem","volume":"558","author":"Watano","year":"2004","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib189","doi-asserted-by":"crossref","first-page":"e70927","DOI":"10.1371\/journal.pone.0070927","article-title":"Microglial P2Y12 deficiency\/inhibition protects against brain ischemia","volume":"8","author":"Webster","year":"2013","journal-title":"PLoS One (Electron. Resour.)"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib190","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s11302-012-9307-6","article-title":"Neuroprotective roles of the P2Y2 receptor","volume":"8","author":"Weisman","year":"2012","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib191","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s12035-012-8263-z","article-title":"P2 receptors for extracellular nucleotides in the central nervous system: role of P2X7 and P2Y2 receptor interactions in neuroinflammation","volume":"46","author":"Weisman","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib192","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/jcp.1041190211","article-title":"Cellular responses to external ATP which precede an increase in nucleotide permeability in transformed cells","volume":"119","author":"Weisman","year":"1984","journal-title":"J.\u00a0Cell Physiol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib193","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2174\/187152712803581047","article-title":"P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential","volume":"11","author":"Weisman","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib194","doi-asserted-by":"crossref","first-page":"e7931","DOI":"10.1371\/journal.pone.0007931","article-title":"Early-onset and robust amyloid pathology in a new homozygous mouse model of Alzheimer's disease","volume":"4","author":"Willuweit","year":"2009","journal-title":"PLoS One (Electron. Resour.)"},{"key":"10.1016\/j.neuropharm.2015.10.031_bib195","doi-asserted-by":"crossref","first-page":"C790","DOI":"10.1152\/ajpcell.00072.2012","article-title":"P2X7 receptor activation induces inflammatory responses in salivary gland epithelium","volume":"303","author":"Woods","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib196","first-page":"1005","article-title":"Inflammation in Alzheimer disease: driving force, bystander or beneficial response?","volume":"12","author":"Wyss-Coray","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib197","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1046\/j.1471-4159.2000.0741017.x","article-title":"Amyloid \u03b2 and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia","volume":"74","author":"Yates","year":"2000","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.10.031_bib198","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1161\/CIRCRESAHA.107.162271","article-title":"Binding of the P2Y2 nucleotide receptor to filamin A regulates migration of vascular smooth muscle cells","volume":"102","author":"Yu","year":"2008","journal-title":"Circ. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815301544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815301544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T08:12:11Z","timestamp":1748679131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815301544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":198,"alternative-id":["S0028390815301544"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.10.031","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Purinergic receptors as potential therapeutic targets in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}